Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpress
Nicolo Girometti A , Sheena McCormack A B * , Emma Devitt A * , Keerti Gedela A * , Nneka Nwokolo A * , Sheel Patel A * , Tara Suchak A * , Alan McOwan A * and Gary Whitlock A C *A 56 Dean Street, Chelsea & Westminster Hospital NHS Foundation Trust, W1D 6AQ, London, UK.
B MRC Clinical Trials Unit at University College of London (UCL), Aviation House, 125 Kingsway, WC2B 6NH, London, UK.
C Corresponding author. Email: gary.whitlock@chelwest.nhs.uk
Sexual Health 15(6) 598-600 https://doi.org/10.1071/SH18055
Submitted: 27 March 2018 Accepted: 21 August 2018 Published: 25 September 2018
Abstract
Screening and treatment of sexually transmissible infections, including HIV, are free in the UK nations; pre-exposure prophylaxis (PrEP) became free in England in October 2017 through the PrEP Impact trial. Doctor-led PrEP clinics started at 56 Dean Street in September 2015, with the drug purchased privately at full price. The service was expanded to other staff to support initiation and monitoring of increasing numbers of attendees purchasing PrEP from online pharmacies. Nonetheless, when the clinic was given a target of 1700 for the PrEP Impact trial, it was clear this could not be achieved in a timely manner through 56 Dean Street alone. To prepare for the trial, all staff with HIV testing competencies were trained in good clinical practice and trial-specific procedures, and a patient group directive was approved to facilitate nurse prescribing and dispensing. Electronic pro formas to capture eligibility for starting or continuing PrEP were adapted for the Dean Street Express clinic, with some information collected directly from service users using touch screens. These interventions, together with an update to the 2016 information leaflet developed by the community, enabled enrolment and follow-up of 1700 participants in 4 months. PrEP advice and monitoring were easily accommodated in the 56 Dean Street sexual health service, but did require additional training and approval for nurse prescribing and dispensing drug in order to achieve the target, which still fell short of the demand.
Additional keywords: HIV, prevention, PrEP monitoring.
References
[1] Whitlock GG, Gibbons DC, Longford N, Harvey MJ, McOwan A, Adams EJ. Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits. Int J STD AIDS 2018; 29 474–82.| Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits.Crossref | GoogleScholarGoogle Scholar |
[2] iBase. Guide to PrEP. 2016. Available online at: http://i-base.info/guides/wp-content/uploads/2016/06/PrEP-leaflet-FINAL1.pdf [verified March 2018].
[3] British HIV Association. PrEP guidance. Available online at: https://www.bhiva.org/file/5b729cd592060/2018-PrEP-Guidelines.pdf [verified August 2018].
[4] Zablotska IB, Selvey C, Guy R, Price K, Holden J, Schmidt HM, McNulty A, Smith D, Jin F, Amin J, , Cooper DA, Grulich AE. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial. BMC Public Health 2018; 18 210
| Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.Crossref | GoogleScholarGoogle Scholar |
[5] Byrne R, Cooper F, Appleby T, Chislett L, Freeman L, Kershaw E, Nwokolo N, Whitlock G, McOwan A. Can express treatment reduce onward transmission? In: Richardson D, editor. Proceedings of the BASHH Spring Conference; 1–3 June 2015; Glasgow, UK. Macclesfield: British Association for Sexual Health and HIV; 2015. [Abstract O19]